期刊文献+

G蛋白抑制性多肽-27药动学测定方法的建立 被引量:1

Development of on Isotope Tracing Method for Pharmacokinetics of GCIP-27
下载PDF
导出
摘要 目的建立测定小鼠血浆中G蛋白抑制性多肽-27(GCIP-27)浓度的放射性核素(125I)示踪测定法。方法125I-GCIP采用Iodogen法标记,血浆中GCIP的浓度采用同位素示踪法结合三氯醋酸(TCA)沉淀法或低相对分子质量SDS-PAGE电泳法测定,并比较其测定结果。结果TCA沉淀法和电泳法同时对照测定60份GCIP血浆样品,结果呈良好的相关性,r=0.9554。2种方法最低检测浓度均为2.0μg.L-1,日内、日间RSD均小于10%,血浆在3.75~480μg.L-1内均呈良好的相关性,相关系数分别为r=0.9977和0.9964,血浆中GCIP的平均回收率分别为(92.72±4.55)%和(91.77±5.21)%。结论同位素示踪法与沉淀法或电泳法结合,方法稳定、可靠、灵敏度较高,两法相辅相成,适于GCIP-27血药浓度测定。 OBJECTIVE To develop an isotope tracing method tor the pharmacokinetics of GCIP-27 in mice. METHODS ^125 I- GCIP was prepared by Iodogen method. Isotope tracing method combined with trichloroacetie acid (TCA) precipitation and low molecular weight SDS-PAGE method were used to determine GCIP-27 in mice plasma. RESULTS TCA method and SDS-PAGE method were used to measure the concentration of 60 mouse plasma samples. There was a good linear correlation ( r = 0. 955 4) between the two methods. Within-day and between-day precision were less than 10%. Their linearities were determined in the range of 3.75 -480 μg ·L^-1 in plasma ( r = 0. 9977 and 0. 996 4, respectively) . The average recoveries of the two methods of GCIP were(92.72±4. 55 ) and (91.77 ± 5.21 )%, respectively. CONCLUSION Both the methods are stable, reliable and sensitive. They are suitable for the detemlination of GCIP concentration in mice plasma.
出处 《中国药学杂志》 CAS CSCD 北大核心 2008年第9期692-695,共4页 Chinese Pharmaceutical Journal
基金 重庆市自然科学基金重点攻关项目(20048256、20027537、20010725)
关键词 G蛋白抑制性多肽-27 同位素标记示踪法 TCA沉淀法 低分子量蛋白电泳法 GCIP-27 isotope tracing method TCA SDS-PAGE
  • 相关文献

参考文献8

二级参考文献39

  • 1周晓莉,雷寒,柳青.血管平滑肌细胞的培养及鉴定[J].重庆医学,2005,34(6):877-878. 被引量:32
  • 2江骥,胡蓓,李晓明,叶云鹏,王世真.人体内川芎嗪药代动力学参数的稳定同位素法测定[J].中国药学杂志,1994,29(7):416-418. 被引量:22
  • 3华英圣,马桂华,刘丽波,林肇群,张剑力,李光华,龙长江,宿少滨.川芎Ⅲ号碱药理作用的初步研究[J].中医药学报,1989,17(2):40-44. 被引量:17
  • 4[1]Copper G 4th. Basic determinants of myocardial hypertrophy: a review of molecular mechanisms[J]. Annu Rev Med, 1997, 48: 13-23.
  • 5[2]Scheuer J. Catecholamines in cardiac hypertrophy[J]. Am J Cardiol, 1999, 83(12A): 70H-74H.
  • 6[3]Akhter S A, Luttrell L M, Rockman H A, et al. Targeting the receptor-Gq interface to inhibit in vivo pressure overload myocardial hypertrophy[J]: Science, 1998, 280(5363): 574-577.
  • 7[4]Eckhart A D, Duncan S J, Penn R B, et al. Hybrid transgenic mice reveal in vivo specificity of G protein-coupled receptor kinases in the heart[J]. Circ Res, 2000, 86(1): 43-50.
  • 8[5]Zolk O, Kouchi I, Schnabel P, et al. Heterotrimeric G proteins in heart disease[J]. Can J Physiol Pharmacol, 2000, 78(3): 187-198.
  • 9[6]Aoki H, Sadoshima J, Izumo S. Myosin light chain kinase mediates sarcomere organization during cardiac hypertrophy in vitro[J]. Nat Med. 2000, 6(2): 183-188.
  • 10[7]Sutsch G, Brunner U T, von Schulthess C, et al. Hemodynamic performance and myosin light chain-1 expression of the hypertrophied left ventricle in aortic valve disease before and after valve replacement[J]. Circ Res, 1992, 70(5): 1035-1043.

共引文献13

同被引文献17

引证文献1

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部